LEXEO Therapeutics Companies
Clinical stage genetic medicine companyLexeo Therapeutics is a clinical stage genetic medicine company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated.Day's Range: 10.30-10.78Open: 10.50Previous Close: 10.50Volume: 30,022Lexeo Therapeutics, Inc. (LXEO) - Stock Analysisstockanalysis.com/stocks/lxeo/
Investors
Headquarters:
Floor, Aert van Nesstraat, Cool, Centrum, Rotterdam, South Holland, Netherlands, 3012 GP, Netherlands
Founded Date:
2018
Employee Number:
11-50
Industry:
AI R&D Pharma (DPI)